The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pathologic determinants of ctDNA-shedding in colorectal cancer metastases.
 
Hiroki Yukami
No Relationships to Disclose
 
Hideaki Bando
Honoraria - Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical
 
Yu Aoki
Honoraria - Daiichi Sankyo; Guardant Health; Ono Pharmaceutical
 
Yuki Matsubara
Honoraria - Bristol Myers Squibb; MSD; Taiho Pharmaceutical
 
Takeshi Kuwata
Honoraria - Agilent; Astellas Pharma; Bristol-Myers Squibb Japan; Daiichi Sankyo; FALCO biosystems; Guardant Health; MSD; Myriad Genetics; Roche
Consulting or Advisory Role - Amgen; Astellas Pharma; Daiichi Sankyo; GxD; Roche
Research Funding - Takeda (Inst)
 
Shingo Sakashita
No Relationships to Disclose
 
Yujiro Nishizawa
No Relationships to Disclose
 
Yoshinori Kagawa
Consulting or Advisory Role - Lilly; Merck; Taiho Pharmaceutical; Takeda Science Foundation
Speakers' Bureau - Bayer; Chugai Pharma; Lilly; Merck; MSD; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Research Funding - Ono Pharmaceutical
 
Yasuhiro Yonezuka
Employment - Sysmex
Stock and Other Ownership Interests - Sysmex
 
Masahiro Nishida
Employment - Sysmex
 
Yuka Oi
Employment - Sysmex
Stock and Other Ownership Interests - Sysmex (I)
 
Naoki Akiyama
Employment - Sysmex
 
Shin Kobayashi
No Relationships to Disclose
 
Naoto Gotohda
No Relationships to Disclose
 
Keiju Aokage
Honoraria - AstraZeneca; Care Net; Chugai Pharma; Covidien; CSL Behring; Daiichi Sankyo/UCB Japan; Fukuyama city hospital; Guardant Health; International Life Sciences Institute; Japan Blood Products Organization; Johnson & Johnson; KANEHARA & Co., LTD; Kyowa Kirin International; Lilly Japan; M3; Mediacal view; Medical market vision; medical tribune; MSD K.K; nankodou; Phase one; Taiho Pharmaceutical; Zaiosoft
Consulting or Advisory Role - AstraZeneca; Olympus Medical Systems; Sano hospital; Taiho Pharmaceutical
Research Funding - AstraZeneca; MSD
 
Masahiro Tsuboi
No Relationships to Disclose
 
Jesus Garcia-Foncillas
No Relationships to Disclose
 
Takayuki Yoshino
Honoraria - Chugai Pharma; Merck; Ono Pharmaceutical; Takeda
Consulting or Advisory Role - Indivumed; Sumitomo Corp.
Research Funding - Bristol-Myers Squibb Japan (Inst); Caris MPI (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); Eisai (Inst); Exact Sciences (Inst); FALCO biosystems Ltd. (Inst); Medical & Biological Laboratories Co., Ltd. (Inst); Merus (Inst); Miyarisan pharmaceutical (Inst); MSD (Inst); Natera (Inst); Nippon Boehringer Ingelheim (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sysmex (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)